NEW YORK (GenomeWeb) – HTG Molecular Diagnostics said after the close of the market Tuesday that it intends to offer 10 million shares of its common stock in an underwritten public offering.

Leerink Partners and Cantor Fitzgerald are acting as joint book-running managers for the offering, and LifeSci Capital is acting as co-manager. HTG expects to grant the underwriters a 30-day option to purchase up to an additional 1.5 million shares of its stock.

The shares are being offered by HTG pursuant to a shelf registration statement filed by the company in April 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.